1942 related articles for article (PubMed ID: 26494508)
21. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
Dong L; Yin L; Quan H; Chu Y; Lu J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057809
[TBL] [Abstract][Full Text] [Related]
22. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
[TBL] [Abstract][Full Text] [Related]
24. Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
Jin H; Jiang Y; Lv W; Chen L; Zheng Y; Lin Y
Mol Cell Probes; 2021 Apr; 56():101706. PubMed ID: 33617946
[TBL] [Abstract][Full Text] [Related]
25. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
26. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
27. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
Lv H; Fan X; Wang L; Feng H; Ci X
Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
[TBL] [Abstract][Full Text] [Related]
28. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
[TBL] [Abstract][Full Text] [Related]
29. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Wu YL; Lian LH; Wan Y; Nan JX
Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
[TBL] [Abstract][Full Text] [Related]
30. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
[TBL] [Abstract][Full Text] [Related]
31. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
[TBL] [Abstract][Full Text] [Related]
32. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
[TBL] [Abstract][Full Text] [Related]
33. Pseudoephedrine/ephedrine shows potent anti-inflammatory activity against TNF-α-mediated acute liver failure induced by lipopolysaccharide/D-galactosamine.
Wu Z; Kong X; Zhang T; Ye J; Fang Z; Yang X
Eur J Pharmacol; 2014 Feb; 724():112-21. PubMed ID: 24365491
[TBL] [Abstract][Full Text] [Related]
34. Modulation of d-galactosamine/lipopolysacharride-induced fulminant hepatic failure by nilotinib.
El-Agamy DS; Shebl AM; Shaaban AA
Hum Exp Toxicol; 2018 Jan; 37(1):51-60. PubMed ID: 28125915
[TBL] [Abstract][Full Text] [Related]
35. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395
[TBL] [Abstract][Full Text] [Related]
36. Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
Lian LH; Jin X; Wu YL; Cai XF; Lee JJ; Nan JX
J Pharmacol Sci; 2010; 114(2):147-57. PubMed ID: 20838028
[TBL] [Abstract][Full Text] [Related]
37. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
38. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of lupeol against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Kim SJ; Cho HI; Kim SJ; Kim JS; Kwak JH; Lee DU; Lee SK; Lee SM
J Nat Prod; 2014 Nov; 77(11):2383-8. PubMed ID: 25325613
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
